Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

Genenta Science S.p.A. (GNTA) Form 6-K — Sep 1, 2026

$GNTAForm 6-KFiled Sep 1, 2026, 5:42 PM ET0001493152-26-041066Original filing

Genenta Science S.p.A. (Nasdaq: GNTA) used a September 2026 Form 6-K to formalize its transformation from a biotechnology company into a long-term strategic industrial consolidator seeking majority or full ownership of profitable privately held Italian companies in aerospace, defense, national security and biotechnology/biosecurity sectors regulated under Italy's Golden Power framework. The current portfolio includes 100% ownership of A.T.C.

Key figures

Atc Ownership Pct
100% (acquisition completed May 2026)
Proposed Icb Code
50201010 - Aerospace / Defense
Proposed Naics Code
336411 - Aircraft Manufacturing
Sophia Ht Ownership Pct
19.9%
Proposed Fact Set Industry
4420 - Aerospace & Defense
Sophia Ht Target Ownership Pct
51% (aggregate, via performance-driven second tranche)

AI analysis

Red flags6 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.